No Data
SANAI HEALTH GP (01889) announced its annual performance, with Shareholder attributable profit of 4.892 million yuan, a decrease of 73.75% year-on-year.
SANAI HEALTH GP (01889) announced its annual performance for the year ending December 31, 2024, with the group achieving revenue...
SANAI HEALTH GP: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2024
SANAI HEALTH GP (01889.HK) will hold a Board of Directors meeting on March 31 to approve the annual performance.
On March 14, Gelonghui announced that SANAI HEALTH GP (01889.HK) will hold a Board of Directors meeting on March 31, 2025, to approve the annual performance announcement for the year ending December 31, 2024, for the company and its subsidiaries.
What does AI pharmaceuticals still lack before a market explosion? | Focus
① From the discovery of targets to the identification of preclinical candidate compounds, current generative AI mainly focuses on the early stages of drug development, which can lead to significant acceleration; ② If AI in drug development is to further expand the realm of possibilities, it must explore more profitable real-world applications.
Sanai Health Industry Group Company Limited (HKG:1889) Not Doing Enough For Some Investors As Its Shares Slump 25%
SANAI HEALTH GP (01889): Chan Wan-fong has been appointed as the company secretary.
SANAI HEALTH GP (01889) announced that Li Wanshan has resigned as (i) company secretary; (ii) Hong Kong joint exchange...
Benign Growth For Sanai Health Industry Group Company Limited (HKG:1889) Underpins Stock's 28% Plummet
